Pharmacielo (PHCEF) Stock Price, News & Analysis

Company Overview

Pharmacielo Ltd. (OTCMKTS:PHCEF) is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of pharmaceutical-grade cannabis-based products. Headquartered in Toronto, Canada, the company employs a proprietary carrier-driven drug delivery platform to optimize the bioavailability and targeted release of active pharmaceutical ingredients. Its primary focus lies in addressing pain management and other therapeutic indications through novel cannabis-derived formulations.

Pharmacielo’s product pipeline features a range of drug delivery modalities including sublingual strips, oral dissolvable films and transdermal patches. These delivery systems are designed to provide precise dosing, rapid onset of action and enhanced patient compliance by reducing variability in absorption. The company aims to extend the therapeutic window of cannabinoids while ensuring consistency and ease of administration.

The company’s operations encompass preclinical research and early-stage clinical programs, with ongoing efforts to secure regulatory approvals in Canada and select international markets. Pharmacielo collaborates with contract research organizations and academic partners to advance its lead candidates through development, while exploring strategic alliances that can accelerate market entry as global regulatory frameworks for medical cannabis evolve.

Key Stats

• Today's Range: $0.05 to $0.05
• 50-Day Range: $0.04 to $0.07
• 52-Week Range: $1.90 to $9.98
• Volume: 15,000 shs
• Average Volume: 64,155 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:PHCEF
• CIK: N/A
• Web: www.pharmacielo.com
• Phone: 647-560-4640
• Fax: N/A
• Employees: 49
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A